Neale BM, et al. Meta-analysis of genome-wide association studies of attention deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2010; 49: 884–897.
Volkow ND, et al. evaluating dopamine reward pathway in ADHD: clinical implications. JAMA 2009; 302: 1084–1091.
Valera EM, et al. Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biol Psychiatry 2007; 61: 1361–1369.
Dickstein SG, et al. The neural correlates of attention deficit hyperactivity disorder: an ALE meta-analysis. J Child Psychol Psychiatry 2006; 147: 1051–1062.
Ivanov I, et al. Morphological abnormalities of the thalamus in youths with attention deficit hyperactivity disorder. Am J Psychiatry 2010; 167: 397–408.
Farone SV, et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005; 57: 1313–1323.
National Institute for Health and Care Excellence. Attention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adults. Clinical guideline 72. Available at: http://guidance.nice.org.uk/cg72 [accessed August 2017].
National Institute for Health and Care Excellence. Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Review of technology appraisal 98. Available at: www.nice.org.uk/TA98 [accessed August 2017].
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Fifth edition. 2013.
Scottish Intercollegiate Guidelines Network. Management of attention deficit and hyperkinetic disorders in children and young people: a national clinical guideline. Guideline 112; October 2009. Available at: http://www.sign.ac.uk/assets/sign112.pdf [accessed August 2017].
Taylor E, et al. European clinical guidelines for hyperkinetic disorder – first upgrade. Eur Child Adolesc Psychiatry 2004; 13 Suppl 1: 117–130.
Chronis AM, et al. Evidence-based psychosocial treatments for children and adolescents with attention-deficit hyperactivity disorder. Clin Psychol Rev 2006; 26: 486–502.
Nigg JT, et al. Meta-analysis of attention-deficit/hyperactivity disorder or attention-deficit/hyperactivity disorder symptoms, restriction diet, and synthetic food color additives. J Am Acad Child Adolesc Psychiatry 2012; 51: 86–97.
ADHD is an abbreviation for Attention Deficit Hyperactivity Disorder. The information provided on this website is not a substitute for professional medical care. As always if you have any concerns about you or your child’s health or medication you should consult your specialist or general practitioner. This site is published by Janssen-Cilag Limited, which is solely responsible for the content. It is intended for a UK audience.